Fidelity Advisor Biotechnology Fund Class C (FBTCX)
The investment seeks capital appreciation. The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.
Fund Info
| ISIN | US3159184742 |
|---|---|
| Issuer | Fidelity |
| Inception Date | Dec 27, 2000 |
| Category | Health & Biotech Equities |
| Min. Investment | $0 |
| Asset Class | Equity |
Asset Class Size | Mid-Cap |
Asset Class Style | Growth |
Expense Ratio
FBTCX has a high expense ratio of 1.75%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: FBTCX vs. BITO, FBTCX vs. GBTC, FBTCX vs. MSFT, FBTCX vs. IBIT, FBTCX vs. VOO
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Fidelity Advisor Biotechnology Fund Class C, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Fidelity Advisor Biotechnology Fund Class C had a return of 7.07% year-to-date (YTD) and 16.20% in the last 12 months. Over the past 10 years, Fidelity Advisor Biotechnology Fund Class C had an annualized return of 8.62%, while the S&P 500 had an annualized return of 10.90%, indicating that Fidelity Advisor Biotechnology Fund Class C did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 7.07% | 11.05% |
| 1 month | 3.88% | 4.86% |
| 6 months | 32.68% | 17.50% |
| 1 year | 16.20% | 27.37% |
| 5 years (annualized) | 9.60% | 13.14% |
| 10 years (annualized) | 8.62% | 10.90% |
Monthly Returns
The table below presents the monthly returns of FBTCX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 4.14% | 6.48% | 1.85% | -8.98% | 7.07% | ||||||||
| 2023 | 1.07% | -3.64% | -2.41% | 3.23% | 0.26% | 0.42% | 2.17% | -3.04% | -4.18% | -5.72% | 4.10% | 19.38% | 9.86% |
| 2022 | -12.79% | 0.21% | 4.75% | -13.21% | -6.23% | 5.45% | 2.61% | 8.40% | -1.98% | 5.40% | 1.60% | -0.41% | -8.64% |
| 2021 | 0.47% | 0.57% | -4.75% | 1.34% | -4.95% | 5.48% | -1.92% | 8.59% | -5.12% | 1.16% | -6.34% | 2.84% | -3.72% |
| 2020 | -5.35% | 0.50% | -6.98% | 14.66% | 11.01% | 2.17% | -3.39% | 1.73% | 1.14% | -1.91% | 12.40% | 4.01% | 31.17% |
| 2019 | 10.25% | 2.74% | 0.61% | -4.13% | -5.71% | 8.55% | -3.90% | -1.80% | -3.14% | 6.54% | 11.41% | 2.87% | 24.82% |
| 2018 | 9.34% | -2.74% | -3.55% | -1.88% | 6.86% | 0.04% | 2.52% | 4.13% | -0.28% | -14.26% | 7.31% | -9.43% | -4.55% |
| 2017 | 5.34% | 9.43% | -0.75% | 0.80% | -6.72% | 10.68% | 2.41% | 5.51% | 2.23% | -6.81% | 0.09% | 1.73% | 24.81% |
| 2016 | -26.58% | -4.81% | 3.18% | 4.29% | 6.95% | -8.94% | 11.18% | -2.73% | 4.73% | -11.92% | 9.36% | -5.07% | -24.14% |
| 2015 | 6.29% | 4.55% | 2.95% | -5.66% | 10.73% | 2.94% | 2.93% | -10.48% | -12.05% | 5.99% | 5.15% | -0.52% | 10.54% |
| 2014 | 11.88% | 7.40% | -12.30% | -5.83% | 2.68% | 7.25% | -2.43% | 12.53% | -1.39% | 8.17% | 2.33% | 1.87% | 33.41% |
| 2013 | 7.08% | 1.97% | 9.55% | 5.76% | 4.39% | -3.26% | 16.33% | -2.70% | 8.74% | -2.80% | 5.26% | 0.98% | 62.44% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of FBTCX is 23, indicating that it is in the bottom 23% of mutual funds on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
FBTCX (Fidelity Advisor Biotechnology Fund Class C)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Fidelity Advisor Biotechnology Fund Class C granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $5.25 | $2.73 | $1.85 | $0.59 | $0.00 | $0.00 | $1.32 | $0.60 | $0.05 |
Dividend yield | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% | 2.75% | 0.31% |
Monthly Dividends
The table displays the monthly dividend distributions for Fidelity Advisor Biotechnology Fund Class C. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $5.24 | $5.25 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.73 | $2.73 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.85 | $1.85 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.59 | $0.59 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.32 | $0.00 | $0.00 | $0.00 | $1.32 |
| 2014 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.18 | $0.00 | $0.00 | $0.42 | $0.60 |
| 2013 | $0.05 | $0.05 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Fidelity Advisor Biotechnology Fund Class C. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Fidelity Advisor Biotechnology Fund Class C was 61.27%, occurring on Jul 10, 2002. Recovery took 2394 trading sessions.
The current Fidelity Advisor Biotechnology Fund Class C drawdown is 12.60%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -61.27% | Jan 30, 2001 | 360 | Jul 10, 2002 | 2394 | Jan 10, 2012 | 2754 |
| -45.26% | Jul 20, 2015 | 144 | Feb 11, 2016 | 1068 | May 11, 2020 | 1212 |
| -43.66% | Dec 16, 2021 | 123 | Jun 13, 2022 | — | — | — |
| -24.4% | Feb 26, 2014 | 34 | Apr 14, 2014 | 135 | Oct 24, 2014 | 169 |
| -17.55% | Feb 9, 2021 | 208 | Dec 3, 2021 | 8 | Dec 15, 2021 | 216 |
Volatility
Volatility Chart
The current Fidelity Advisor Biotechnology Fund Class C volatility is 4.57%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.